24 May 2013
Keywords: second, ph, iii, study, oxytrex, starts, pain
Article | 05 April 2004
Pain Therapeutics has initiated a second Phase III trial for its oral painkiller Oxytrex. The study will evaluate the safety ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 April 2004
23 May 2013
© 2013 thepharmaletter.com